Malignant Biliary Tract Neoplasm — Trials

Malignant Biliary Tract Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,281 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 366
Recruiting: 208
Ph III recruiting: 19
Growth YoY: +14.8%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (152)

clinicaltrialsPublishedShowing 101–150 of 1,281 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06899152	HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer(HepQuant)	recruiting	N/A	40	Montefiore Medical CenterOTHER	1	Aug 11, 2026	clinicaltrials
NCT07486713	Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies	recruiting	Phase 4	16	Rigel PharmaceuticalsINDUSTRY	1	Aug 11, 2026	clinicaltrials